Inventage Lab will attend the 16th American Drug Delivery & Formulation (DDF) Summit 2026, taking place September 14–15, 2026 at the Omni Boston Hotel at the Seaport in Boston, USA.
Hosted by Mark Allen Group, the American DDF Summit is a leading North American forum dedicated to drug delivery and formulation science, convening 450+ scientific leaders from the pharma, biotech, and drug delivery industries. Its four parallel tracks Small Molecules, Biologics, Technology & Innovation, and Device Development provide focused coverage of the latest formulation and delivery technologies and real-world development case studies.
Inventage Lab is a clinical-stage biotech developing next-generation drug delivery platforms based on its proprietary microfluidic technology. At DDF 2026, the company will focus discussions on DrugFluidic®, its long-acting injectable (LAI) platform for small molecules and peptides, and BioFluidic™, its platform for subcutaneous (SC) formulation optimization of antibody and protein therapeutics.
Inventage Lab will attend with a focus on meetings and networking, exploring co-development, and licensing partnership opportunities with global pharmaceutical and biotech companies. Companies interested in meeting on-site are welcome to get in touch.
